1,2,5-trihydroxybenzene

Product name:1,2,5-trihydroxybenzene
CAS:     108-73-6
Molecular Formula:     C6H6O3
Formula Weight:126.11
Description:
Melting point:215-220 °C
Boiling point:331.1 °C at 760 mmHg
Flash Point:174.9 °C
Density:1.488g/cm³
Chemical property:white to light yellow crystal
Storage:In ventilate,cool and dry places. 
For more, please click:sales@acridine-raw-material.com

D-Pantoyl lactone

Product name:D-Pantoyl lactone
CAS:599-04-2
Molecular Formula:C6H10O3
Formula Weight:130.14
Description:
Melting point:91 °C(lit.)
Boiling point:120-122 °C15 mm Hg(lit.)
Flash Point:99°C
Density:1.165g/cm³
Appearance: White crystal powder.
Character: It dissolves easily in water, alcohol, methanol and propylene glycol.
Usage: The intermediate to produce D-panthenol and other composites.
Storage: to keep in the dry, off-light and ventilative place.
For more, please click:sales@acridine-raw-material.com

Gamma Oryzanol

Product name:Gamma Oryzanol
CAS:11042-64-1
Molecular Formula:C40H58O4
Formula Weight:602.89
Description:
Melting point:135-137 ºC
Boiling point:663.2 °C at 760 mmHg
Flash Point:193.8 °C
Density:1.1 g/cm³
Chemical property:White or white crystalline powder, odourless
                                   Soluble in acetone, chloroform, sparingly soluble in ethanol, n-heptane, insoluble in water.
Use:Used in Periodic mental disease,premenstrual tension,women's Menopause Syndrome and vascular headache etc.
Would like to ask specific details, please click here Email:sales@acridine-raw-material.com

Vinylmagnesium bromide

Product name:Vinylmagnesium bromide
CAS:1826-67-1
Molecular Formula:C2H3BrMg
Formula Weight:131.25
Description:
Density:0.981 g/mL at 25 °C
Flash Point:-17 oC
Solubility:vigorous reaction.
Storage:Refrigerator.
Soubility:vigorous reaction
Use:Used as medicine intermediate.
For more, please click:sales@acridine-raw-material.com

What is SelectFluoro

Replacement of hydrogen atoms by fluorine substituents into organic substrates is of great interest in synthetic chemistry due to the high electronegativity of fluorine and relatively small steric hindrance fluorine atoms. Many nucleophilic fluorine sources are available for the derivatization of organic molecules under acidic conditions, basic and neutral. However, electrophilic fluorination historically required molecular fluorine, whose notorious toxicity and explosive tendencies limit its application in research. The need for an electrophilic fluorination reagent, secure, stable, highly responsive and accessible to industrial production as an alternative, it is very hazardous molecular fluorine was the inspiration for the discovery of Select. This reagent is not only an electrophilic fluorination of available reagent, but it is also safe, non-toxic and easy to handle. In this article, we describe the many applications Select and discuss possible ways for its reaction.

9-bromo-1-nonanol

9-bromo-5-morpholino-tetrazole [1,5-c] quinoline cytotoxicity (BMT) is applied to the cell line L1210 murine leukemia and carcinoma cells of the Caco-2 colon. We have the two highest concentrations of BMTQ (149.2 and 74.6 microM) induces an acute cytotoxic effect, but other concentrations tested (<74.6 microM) exhibits a / dependent cytotoxic effect depending on the time and / concentration. The sensitivity of mouse leukemia L1210 cells and carcinoma cells of the Caco-2 colon was expressed in the same order. Cytotoxicity BMTQ not bound by changes in the cell cycle profile. After the effects of cytotoxicity associated BMTQ we observed induction of ssDNA breaks after BMTQ treatment. All BMTQ concentrations increases the level of ssDNA breeze 1.3-2.9 times (after 2 hours of treatment) and 1.6-2.8 times (after 4 hours of treatment) in Caco-2 cells compared to control. No apoptotic DNA fragmentation was induced by BMTQ in Caco-2 cells is recorded.

Would like to ask specific details, please click here Email:sales@chemicals-chemicals.net

2-butenoic acid for sale

Thirty-nine evaluable patients with squamous cell lung cancer treated with combination chemotherapy consisting of doxorubicin, Oncovin, bleomycin, cisplatin and cytembena. Objective responses were seen in 46 percent of patients. Patients with the disease had a rate of 56 percent response. Two of the four complete responses were verified endoscopically and histologically. The median survival was 37.6 and 26.3 weeks for patients with limited and extensive disease (p less than 0.05) and 29.9 weeks for the entire group. Haematological toxicities and gastrointestinal were moderate. There was a drug-related death due to sepsis and 2 reversible acute renal failure. The chemotherapeutic combination seems relatively effective. It causes a regression of the tumor, and possibly survival of responder patients with acceptable quality to increase. Maintenance chemotherapy with CCNU, cyclophosphamide, methotrexate, procarbazine be removed alternating with vinblastine, nitrogen mustard, methotrexate, procarbazine, often caused because of severe toxicity.